Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma

DOI: 10.1080/2162402X.2015.1052212

Keywords: checkpoint blockade, immunotherapy, melanoma, PD-1, targeted therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text